Boiogito (BOT) ameliorates insulin resistance and diabetes in several animal models; however, the underlying mechanisms for these in vivo effects remain unclear. Thiazolidine derivatives, which are peroxisome proliferator-activated receptor γ (PPAR γ ) agonists for the treatment of type II diabetes, promote adiponectin production by inducing adipocyte differentiation, thereby reducing insulin resistance. This study aimed to evaluate the effect of BOT on adipocyte differentiation using cultured human visceral preadipocytes (HVPAds) compared with the thiazolidine derivative troglitazone (TRG). We investigated the effects of BOT (0.125 - 1 mg/mL) and TRG (10 μM) on the differentiation of adipocytes treated with or without tumor necrosis factor- α (TNF- α : 5 ng/mL). On day 14 of culture, the following adipocyte differentiation marker levels were measured: intracellular lipids, extracellular ( i.e. , medium) adiponectin, and intracellular differentiation-related genes (PPAR γ , CCAAT/enhancer binding protein, adiponectin, differentiation cluster 36, glucose transporter type 4). BOT and TRG increased factors associated with differentiation including lipid, adiponectin, and differentiation-related gene expression levels compared with the controls. The increases in these differentiation markers were inhibited by the PPAR γ antagonist GW9662 (20 μM). Furthermore, TNF- α decreased all differentiation marker levels. The decreases in differentiation markers were inhibited by BOT and TRG; however, these inhibitory effects were blocked by GW9662. The results suggest that BOT increases the synthesis and secretion of adiponectin by promoting differentiation similar to TRG. This study is the first to demonstrate that adipocyte differentiation-promoting activity is a mechanism for the beneficial effects of BOT on diabetes and insulin resistance.
Ouchi, N., Parker, J.L., Lugus, J.J., et al. (2011) Adipokines in Inflammation and Metabolic Disease. Nature Reviews Immunology, 11, 85-97. https://doi.org/10.1038/nri2921
Reaven, G.M. (2011) Insulin Resistance: The Link between Obesity and Cardiovascular Disease. Medical Clinics of North America, 95, 875-892. https://doi.org/10.1016/j.mcna.2011.06.002
Kadowaki, T., Yamauchi, T., Kubota, N., et al. (2006) Adiponectin and Adiponectin Receptors in Insulin Resistance, Diabetes, and the Metabolic Syndrome. Journal of Clinical Investigation, 116, 1784-1792. https://doi.org/10.1172/JCI29126
Rui, L., Aguirre, V., Kim, J.K., et al. (2001) Insulin/IGF-l and TNF-α Stimulate Phosphorylation of IRS-l at Inhibitory Ser307 via Distinct Pathways. Journal of Clinical Investigation, 107, 181-189. https://doi.org/10.1172/JCI10934
Longo, M., Zatterale, F., Naderi, J., et al. (2019) Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications. International Journal of Molecular Sciences, 20, Article No. 2358. https://doi.org/10.3390/ijms20092358
Christiansen, T., Richelsen, B. and Bruun, J.M. (2005) Monocyte Chemoattractant Protein-1 Is Produced in Isolated Adipocytes, Associated with Adiposity and Reduced after Weight Loss in Morbid Obese Subjects. International Journal of Obesity (London), 29, 146-150. https://doi.org/10.1038/sj.ijo.0802839
Lau, D.C., Dhillon, B., Yan, H., Szmitko, P.E. and Verma, S. (2005) Adipokines: Molecular Links between Obesity and Atherosclerosis. American Journal of Physiology-Heart and Circulation Physiology, 288, H2031-H2041. https://doi.org/10.1152/ajpheart.01058.2004
Kurebayashi, S., Sumitani, S., Kasayama, S., Jetten, A.M. and Hirose, Y. (2001) TNF-α Inhibits 3T3-L1 Adipocyte Differentiation without Downregulating the Expression of C/EBPβ and δ. Endocrine Journal, 48, 249-253. https://doi.org/10.1507/endocrj.48.249
Suganami, T., Tanimoto-Koyama, K., Nishida, J., et al. (2007) Role of the Toll-Like Receptor 4/NF-κB Pathway in Saturated Fatty Acid-Induced Inflammatory Changes in the Interaction between Adipocytes and Macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 84-91. https://doi.org/10.1161/01.ATV.0000251608.09329.9a
Akash, M.S.H., Rehman, K. and Liaqat, A. (2018) Tumor Necrosis Factor-α: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus. Journal of Cellular Biochemistry, 119, 105-110. https://doi.org/10.1002/jcb.26174
Bray, G.A., Clearfield, M.B., Fintel, D.J. and Nelinson, D.S. (2009) Overweight and Obesity: The Pathogenesis of Cardiometabolic Risk. Clinical Cornerstone, 9, 30-40. https://doi.org/10.1016/S1098-3597(09)80003-3
Miyazaki, Y., Mahankali, A., Wajcberg, E., et al. (2004) Effect of Pioglitazone on Circulating Adipocytokine Levels and Insulin Sensitivity in Type 2 Diabetic Patients. Journal of Clinical Endocrinology and Metabolism, 89, 4312-4319. https://doi.org/10.1210/jc.2004-0190
Nagashima, K., Lopez, C., Donovan, D., et al. (2005) Effects of the PPARγ Agonist Pioglitazone on Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus. Journal of Clinical Investigation, 115, 1323-1332. https://doi.org/10.1172/JCI23219
Okuno, A., Tamemoto, H., Tobe, K., et al. (1998) Troglitazone Increases the Number of Small Adipocytes without the Change of White Adipose Tissue Mass in Obese Zucker Rats. Journal of Clinical Investigation, 101, 1354-1361. https://doi.org/10.1172/JCI1235
Yamauchi, T., Kamon, J., Waki, H., et al. (2001) The Mechanisms by Which both Heterozygous Peroxisome Proliferator-Activated Receptor Gamma (PPAR gamma) Deficiency and PPAR gamma Agonist Improve Insulin Resistance. Journal of Biological Chemistry, 276, 41245-41254. https://doi.org/10.1074/jbc.M103241200
Kadowaki, T. (2000) Insights into Insulin Resistance and Type 2 Diabetes from Knockout Mouse Models. Journal of Clinical Investigation, 106, 459-465. https://doi.org/10.1172/JCI10830
Yamakawa, J., Moriya, J., Takeuchi, K., et al. (2013) Significance of Kampo, Japanese Traditional Medicine, in the Treatment of Obesity: Basic and Clinical Evidence. Evidence-Based Complementary and Alternative Medicine, 2013, Article ID: 943075. https://doi.org/10.1155/2013/943075
Tsutsumi, T., Kobayashi, S., Liu, Y.Y. and Kontani H. (2003) Anti-Hyperglycemic Effect of Fangchinoline Isolated from Stephania Tetrandra Radix in Streptozotocin-Diabetic Mice. Biological and Pharmaceutical Bulletin, 26, 313-317. https://doi.org/10.1248/bpb.26.313
Yamakawa, J., Moriya, J., Takahashi, T., et al. (2010) A Kampo Medicine, Boi-ogi-to, Inhibits Obesity in Ovariectomized Rats. Evidence-Based Complementary and Alternative Medicine, 7, 87-95. https://doi.org/10.1093/ecam/nem153
Shimada, T., Akase, T., Kosugi, M. and Aburada, M. (2011) Preventive Effect of Boiogito on Metabolic Disorders in the TSOD Mouse, a Model of Spontaneous Obese Type II Diabetes Mellitus. Evidence-Based Complementary and Alternative Medicine, 2011, Article ID: 931073. https://doi.org/10.1093/ecam/nep012
Isa, Y., Miyakawa, Y., Yanagisawa, M., et al. (2011) 6-Shogaol and 6-Gingerol, the Pungent of Ginger, Inhibit TNF-α Mediated Downregulation of Adiponectin Expression via Different Mechanisms in 3T3-L1 Adipocytes. Biochemical and Biophysical Research Communications, 373, 429-434. https://doi.org/10.1016/j.bbrc.2008.06.046
Sakurai, M., Hu, A., Yamaguchi, T., et al. (2022) The Bioactive Flavonoid Taxifolin Inhibits Differentiation and the Production of the Inflammatory Cytokine Interleukin-6 in Cultured Human Adipocytes. Advances in Pharmacology & Clinical Trials, 7, Article ID: 000195. https://doi.org/10.23880/apct-16000195
Fu, Y., Luo, N., Klein, R.L. and Garvey, W.T. (2005) Adiponectin Promotes Adipocyte Differentiation, Insulin Sensitivity, and Lipid Accumulation. Journal of Lipid Research, 46, 1369-1379. https://doi.org/10.1194/jlr.M400373-JLR200
Mitani, T., Watanabe, S., Yoshioka, Y., et al. (2017) Theobromine Suppresses Adipogenesis through Enhancement of CCAAT-Enhancer-Binding Protein β Degradation by Adenosine Receptor A1. Biochimica et Biophysica Acta-Molecular Cell Research, 1864, 2438-2448. https://doi.org/10.1016/j.bbamcr.2017.09.017
Zoico, E., Garbin, U., Olioso, D., et al. (2009) The Effects of Adiponectin on Interleukin-6 and MCP-1 Secretion in Lipopolysaccharide-Treated 3T3-L1 Adipocytes: Role of the NF-κB Pathway. International Journal of Molecular Medicine, 24, 847-851. https://doi.org/10.3892/ijmm_00000302
Lim, J.Y., Kim, W.H. and Park, S.I. (2008) GO6976 Prevents TNF-α-Induced Suppression of Adiponectin Expression in 3T3-L1 Adipocytes: Putative Involvement of Protein Kinase C. Federation of European Biochemical Societies Letters, 582, 3473-3478. https://doi.org/10.1016/j.febslet.2008.09.012
Szalkowski, D., White-Carrington, S., Berger, J. and Zhang, B. (1995) Antidiabetic Thiazolidinediones Block the Inhibitory Effect of Tumor Necrosis Factor-α on Differentiation, Insulin-Stimulated Glucose Uptake, and Gene Expression in 3T3-L1 Cells. Endocrinology, 136, 1474-1481. https://doi.org/10.1210/endo.136.4.7895657
Ikarashi, Y. and Mizoguchi, K. (2016) Neuropharmacological Efficacy of the Traditional Japanese Kampo Medicine Yokukansan and Its Active Ingredients. Pharmacology & Therapeutics, 166, 84-95. https://doi.org/10.1016/j.pharmthera.2016.06.018